Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of new peer-reviewed research in The Journal of Clinical Psychiatry demonstrating how the Tardive Dyskinesia Impact Scale ...

Among more than 2,000 patients who completed a TDScreen assessment, 156 received a Tardive Dyskinesia diagnosis and 125 were prescribed treatment, real-world evidence that AI-enabled screening is ...

Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of exposure to neuroleptic medications," said Jeff Bronstein, MD, PhD, of the ...

Tardive dyskinesia (TD) is a side effect of antipsychotic or neuroleptic medications that causes involuntary movements of the face, neck, arms, and legs. These movements can affect social life, ...

Tardive dyskinesia causes repeated, uncontrollable movements in the face and body. It is a side effect of some neuroleptic or antipsychotic medications. These medications may change dopamine activity ...

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

This section presents medications that are known to potentially lead to 'Dyskinesia' as a side effect. It's important to note that mild side effects are quite common with medications. Please be aware ...

Amantadine extended-release (ER) capsules reduce levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD), a phase 3 placebo-controlled trial has shown. "Our study showed that this ...

Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...